The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Canning John Charles | Chief Operating Officer | Grant(A) | 150K | — | $0 |
| Mar 19, 2026 | Larsen Charles | Director | Grant(A) | 34K | — | — |
| Mar 19, 2026 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 68K | — | — |
| Mar 19, 2026 | Eichenbaum Kenneth D. | Director | Grant(A) | 102K | — | — |
| Mar 19, 2026 | Elefant Dov | Chief Financial Officer | Grant(A) | 34K | — | — |
| Mar 18, 2026 | Eichenbaum Kenneth D. | Director | Grant(A) | 35K | — | $0 |
| Feb 19, 2026 | Elefant Dov | Chief Financial Officer | Grant(A) | 169K | — | $0 |
| Feb 19, 2026 | Elefant Dov | Chief Financial Officer | Grant(A) | 173K | — | $0 |
| Feb 19, 2026 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 282K | — | $0 |
| Feb 19, 2026 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 447K | — | $0 |
| Feb 2, 2026 | Sipos Jeremy Alexander | Chief Technology Officer | Grant(A) | 80K | — | $0 |
| Nov 7, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 0 | — | — |
| Nov 7, 2025 | Larsen Charles | Director | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Larsen Charles | Director | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Larsen Charles | Director | Discretionary(I) | 34K | — | — |
| Nov 7, 2025 | Larsen Charles | Director | Discretionary(I) | 0 | — | — |
| Nov 7, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 68K | — | — |
| Nov 7, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 0 | — | — |
| Nov 7, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 68K | — | — |
| Nov 7, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 68K | — | — |
| Aug 27, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 49K | — | — |
| Aug 27, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 49K | — | — |
| Aug 27, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 39K | — | — |
| Aug 27, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 39K | — | — |
| Jun 25, 2025 | Silverman Joshua | Director | Grant(A) | 18K | — | $0 |
| Jun 25, 2025 | Larsen Charles | Director | Grant(A) | 18K | — | $0 |
| Jun 25, 2025 | Milnes Alistair | Director | Grant(A) | 18K | — | $0 |
| Jun 25, 2025 | Uzialko Edward R | Director | Grant(A) | 18K | — | $0 |
| Jun 23, 2025 | Nicholas Kelley Stinson | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Jun 2, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Discretionary(I) | 34K | $1.02 | $35K |
| Jun 2, 2025 | Elefant Dov | Chief Financial Officer | Discretionary(I) | 20K | $1.02 | $20K |
| Jun 2, 2025 | Currie Daniel Scott | Chief Operating Officer | Discretionary(I) | 20K | $1.02 | $20K |
| Jun 2, 2025 | Larsen Charles | Director | Discretionary(I) | 25K | $1.02 | $25K |
| Jan 29, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 60K | — | $0 |
| Jan 29, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 120K | — | $0 |
| Jan 29, 2025 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 263K | — | $0 |
| Jan 28, 2025 | Elefant Dov | Chief Financial Officer | Grant(A) | 114K | — | $0 |
| Jan 28, 2025 | Elefant Dov | Chief Financial Officer | Grant(A) | 72K | — | $0 |
| Jan 28, 2025 | Thomas Christine E | Chief Reg & Clinical Officer | Grant(A) | 24K | — | $0 |
| Jan 28, 2025 | Thomas Christine E | Chief Reg & Clinical Officer | Grant(A) | 55K | — | $0 |
| Jan 28, 2025 | Thomas Christine E | Chief Reg & Clinical Officer | Grant(A) | 29K | — | $0 |
| Jan 28, 2025 | Currie Daniel Scott | Chief Operating Officer | Grant(A) | 29K | — | $0 |
| Jan 28, 2025 | Currie Daniel Scott | Chief Operating Officer | Grant(A) | 59K | — | $0 |
| Jan 28, 2025 | Currie Daniel Scott | Chief Operating Officer | Grant(A) | 141K | — | $0 |
| Jul 12, 2024 | Uzialko Edward R | Director | Grant(A) | 18K | — | $0 |
| Jul 12, 2024 | Milnes Alistair | Director | Grant(A) | 18K | — | $0 |
| Jul 12, 2024 | Larsen Charles | Director | Grant(A) | 18K | — | $0 |
| Jul 12, 2024 | Silverman Joshua | Director | Grant(A) | 18K | — | $0 |
| Feb 12, 2024 | Spector Richard D. | Chief Commercial Officer | Grant(A) | 100K | — | $0 |
| Feb 1, 2024 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 205K | — | $0 |
| Feb 1, 2024 | Thomas Christine E | SVP, Regulatory & Clinical | Grant(A) | 33K | — | $0 |
| Feb 1, 2024 | Elefant Dov | Chief Financial Officer | Grant(A) | 84K | — | $0 |
| Feb 1, 2024 | Currie Daniel Scott | Chief Operating Officer | Grant(A) | 62K | — | $0 |
| Nov 21, 2023 | Silverman Joshua | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2023 | Thomas Christine E | SVP, Regulatory & Clinical | Grant(A) | 60K | — | $0 |
| Jul 3, 2023 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 272K | — | $0 |
| Jul 3, 2023 | Lee-Sepsick Kathy | Chief Executive Officer, Director | Grant(A) | 270K | — | $0 |
| Jul 3, 2023 | Currie Daniel Scott | Senior VP, Operations | Grant(A) | 125K | — | $0 |
| Jul 3, 2023 | Currie Daniel Scott | Senior VP, Operations | Grant(A) | 85K | — | $0 |
| Jul 3, 2023 | Elefant Dov | Chief Financial Officer | Grant(A) | 105K | — | $0 |
| Jul 3, 2023 | Elefant Dov | Chief Financial Officer | Grant(A) | 205K | — | $0 |
| Jun 21, 2023 | Uzialko Edward R | Director | Grant(A) | 9K | — | $0 |
| Jun 21, 2023 | Perrow Wendy | Director | Grant(A) | 9K | — | $0 |
| Jun 21, 2023 | Larsen Charles | Director | Grant(A) | 9K | — | $0 |
| Jun 21, 2023 | Morrissey Anne | Director | Grant(A) | 9K | — | $0 |
| Jun 14, 2023 | Kendall Keith J | Director | Grant(A) | 17K | — | $0 |
| Jun 14, 2023 | Milnes Alistair | Director | Grant(A) | 17K | — | $0 |
| Oct 10, 2022 | Thomas Christine E | SVP, Regulatory & Clinical | Grant(A) | 50K | — | $0 |
| Jun 8, 2022 | Uzialko Edward R | Director, 10% Owner | Grant(A) | 9K | — | $0 |
| Jun 8, 2022 | Adams John Q JR | Director | Grant(A) | 9K | — | $0 |
| Jun 8, 2022 | Larsen Charles | Director | Grant(A) | 9K | — | $0 |
| Jun 8, 2022 | Morrissey Anne | Director | Grant(A) | 9K | — | $0 |
| Jun 8, 2022 | Perrow Wendy | Director | Grant(A) | 9K | — | $0 |
| Jun 8, 2022 | Dyett John | Director | Grant(A) | 9K | — | $0 |
| Feb 28, 2022 | Elefant Dov | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Jan 25, 2022 | Perrow Wendy | Director | Grant(A) | 17K | — | $0 |
| Jan 25, 2022 | Currie Daniel Scott | Senior VP, Operations | Grant(A) | 20K | — | $0 |
| Dec 15, 2021 | Dyett John | Director | Other(J) | 3.2M | — | $0 |
| Dec 15, 2021 | Dyett John | Director | Other(J) | 176K | — | $0 |
| Dec 15, 2021 | Witte William Benson | Director | Other(J) | 12K | — | $0 |
| Jun 23, 2021 | Dyett John | Director, 10% Owner | Buy(P) | 1K | $9.95 | $10K |
| Jun 22, 2021 | Uzialko Edward R | Director | Conversion(C) | 1.1M | — | — |
| Jun 22, 2021 | Uzialko Edward R | Director | Conversion(C) | 30K | — | — |
| Jun 22, 2021 | Uzialko Edward R | Director | Conversion(C) | 1.1M | — | — |
| Jun 22, 2021 | Uzialko Edward R | Director | Conversion(C) | 30K | — | — |
| Jun 22, 2021 | Uzialko Edward R | Director | Buy(P) | 100K | $13.00 | $1.3M |
| Jun 22, 2021 | Larsen Charles | Director | Conversion(C) | 11K | — | — |
| Jun 22, 2021 | Larsen Charles | Director | Conversion(C) | 11K | — | — |
| Jun 22, 2021 | Larsen Charles | Director | Buy(P) | 7K | $13.00 | $91K |
| Jun 22, 2021 | Adams John Q JR | Director | Conversion(C) | 91K | — | — |
| Jun 22, 2021 | Adams John Q JR | Director | Conversion(C) | 109K | — | — |
| Jun 22, 2021 | Adams John Q JR | Director | Conversion(C) | 91K | — | — |
| Jun 22, 2021 | Adams John Q JR | Director | Conversion(C) | 109K | — | — |
| Jun 22, 2021 | Adams John Q JR | Director | Buy(P) | 40K | $13.00 | $520K |
| Jun 22, 2021 | Dyett John | Director, 10% Owner | Conversion(C) | 2.3M | — | — |
| Jun 22, 2021 | Dyett John | Director, 10% Owner | Conversion(C) | 64K | — | — |
| Jun 22, 2021 | Dyett John | Director, 10% Owner | Conversion(C) | 948K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).